The rise of intoxicating hemp products presents a complex and evolving challenge. Failing to address this challenge effectively could have serious consequences for public health, consumer safety, and the integrity of the legal cannabis market.
Whether for skin wounds, ulcers, skin cancer, or pain, topical delivery of cannabinoids is an excellent way to benefit from its anti-inflammatory and antioxidant properties. After all, the skin is well-known for its abundance of cannabinoid receptors, both CB1 and CB2. These are particularly found in skin cells including the sebaceous glands, keratinocytes, and even various sensory neurons.
Recent research has revealed that children exposed to cannabis smoke in their homes are at risk of testing positive for tetrahydrocannabinol (THC), the psychoactive compound in cannabis. This finding raises significant concerns about the health, safety, and developmental outcomes for these children.
As I scrolled through Reddit the other day, I stumbled upon a question that perfectly encapsulates the absurdity of modern drug policy: "Why is alcohol legal but cannabis isn't?" The responses were predictably brief, with most users simply typing "politics" and calling it a day. While they're not wrong, this answer barely scratches the surface of a complex and fascinating history of prohibition, propaganda, and profit.
The legal cannabis industry in the United States achieved a groundbreaking milestone in 2024, with total sales surpassing $30 billion. This remarkable achievement underscores the rapid growth and normalization of cannabis as both a medical and recreational product, reflecting shifting societal attitudes, legislative reforms, and an evolving consumer market.
On January 21st, 2025, he took office, but we’re yet to find out if he’s the great threat to cannabis rescheduling that we think he is. Having Maltz in the DEA office could quite literally be a cannabis prohibitionist’s dream: he has all the right ingredients in place to keep cannabis illegal and stop it from progressing. Rescheduling? Don’t even think about it.
Remember that uncomfortable moment when your parents caught you smoking weed? That dreaded "Talk" that followed - where you sat squirming in your chair while they cycled through concern, disappointment, and those well-worn warnings about the dangers of marijuana. Even though you knew they meant well, it felt like an eternity of awkward silence punctuated by cautionary tales and stern looks.
More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna. According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry.
Advocacy groups are closely monitoring legislative developments and public sentiment, identifying specific states that are likely to make significant strides toward legalization. This article explores the states most likely to legalize marijuana in 2025, examining the political climate, public opinion, and advocacy efforts that may influence these changes.
The researchers then analyzed the mood and emotional regulation capabilities of the participants during times of sobriety as well as when they were stoned from weed. Surprisingly, they found that the subjects’ performance didn’t differ when made to undergo several tasks after smoking weed.